M. Wied

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial

Rudolf Arnold, Anja Rinke, Klaus‐Jochen Klose et al. · Clinical Gastroenterology and Hepatology · 2005 · 252 citations · Full text

Endocrine Oncology, Surgical Oncology, Gastrointestinal Oncology +10

Placebo-controlled, double-blind, prospective, randomized study of the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group

R. Arnold, Carmen Schade‐Brittinger, Anja Rinke et al. · Journal of Clinical Oncology · 2009 · 197 citations

Octreotide Lar, Surgical Oncology, Median Time +16

Transarterial Chemoembolization of Advanced Liver Metastases of Neuroendocrine Tumors – A Retrospective Single-Center Analysis

Oliver Kress, Hans‐Joachim Wagner, M. Wied et al. · Digestion · 2003 · 149 citations

Influence of Somatostatin Receptor Scintigraphy and CT/MRI on the Clinical Management of Patients with Gastrointestinal Neuroendocrine Tumors: An Analysis in 188 Patients

Martin Gotthardt, Larissa M. Dirkmorfeld, M. Wied et al. · Digestion · 2003 · 28 citations